Literature DB >> 35972557

Bridge centrality network structure of negative symptoms in people with schizophrenia.

Ling-Ling Wang1,2, Michelle H W Tam3, Karen K Y Ho3, Karen S Y Hung3, Jessica O Y Wong3, Simon S Y Lui4, Raymond C K Chan5,6.   

Abstract

Negative symptoms are complex psychopathology. Although evidence generally supported the NIMH five consensus domains, research seldom examined measurement invariance of this model, and domain-specific correspondence across multiple scales. This study aimed to examine the interrelationship between negative symptom domains captured by different rating scales, and to examine the domain-specific correspondence across multiple scales. We administered the Brief Negative Symptom Scale (BNSS), the Self-evaluation of Negative Symptoms (SNS), and the Scale for Assessment of Negative Symptoms (SANS) to 204 individuals with schizophrenia. We used network analysis to examine the interrelationship between negative symptom domains. Besides regularized partial correlation network, we estimated bridge centrality indices to investigate domain-specific correspondence, while taking each scale as an independent community. The regularized partial correlation network showed that the SNS nodes clustered together, whereas the SANS and the BNSS nodes intermingled together. The SANS attention domain lied at the periphery of the network according to the Fruchterman-Reingold algorithm. The SANS anhedonia-asociality (strength = 1.48; EI = 1.48) and the SANS affective flattening (strength = 1.06; EI = 1.06) had the highest node strength and EI. Moreover, the five nodes of the BNSS bridged the nodes of the SANS and the SNS. BNSS blunted affect (strength = 0.76; EI = 0.76) and SANS anhedonia-asociality (strength = 0.76; EI = 0.74) showed the highest bridge strength and bridge EI. The BNSS captures negative symptoms and bridges the symptom domains measured by the SANS and the SNS. The three scales showed domain-specific correspondence.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Bridge centrality; Measurement invariance; Negative symptoms; Network analysis

Year:  2022        PMID: 35972557     DOI: 10.1007/s00406-022-01474-w

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.760


  23 in total

1.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

2.  Validation of the traditional script Chinese version of the brief negative symptom scale.

Authors:  Jessica Sun; Edgar Wing Ka Ching; Gregory P Strauss; Anthony O Ahmed; William Wing Ho Chui; Joyce Suet Yan Chow
Journal:  Asian J Psychiatr       Date:  2020-12-15

3.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

4.  Cross-cultural Validation of the 5-Factor Structure of Negative Symptoms in Schizophrenia.

Authors:  Anthony O Ahmed; Brian Kirkpatrick; Silvana Galderisi; Armida Mucci; Alessandro Rossi; Alessandro Bertolino; Paola Rocca; Mario Maj; Stefan Kaiser; Martin Bischof; Matthias N Hartmann-Riemer; Matthias Kirschner; Karoline Schneider; Maria Paz Garcia-Portilla; Anna Mane; Miguel Bernardo; Emilio Fernandez-Egea; Cui Jiefeng; Yao Jing; Tan Shuping; James M Gold; Daniel N Allen; Gregory P Strauss
Journal:  Schizophr Bull       Date:  2019-03-07       Impact factor: 9.306

5.  Validation of the German version of the Clinical Assessment Interview for Negative Symptoms (CAINS).

Authors:  Maike Engel; Anja Fritzsche; Tania Marie Lincoln
Journal:  Psychiatry Res       Date:  2014-08-01       Impact factor: 3.222

6.  Validation of the Spanish version of the Clinical Assessment for Negative Symptoms (CAINS).

Authors:  Alicia Valiente-Gómez; Gisela Mezquida; Anna Romaguera; Irene Vilardebò; Helena Andrés; Bianca Granados; Jesús Larrubia; Edith Pomarol-Clotet; Peter J McKenna; Salvador Sarró; Miguel Bernardo
Journal:  Schizophr Res       Date:  2015-06-23       Impact factor: 4.939

7.  A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale.

Authors:  Armida Mucci; Annarita Vignapiano; István Bitter; Stephen F Austin; Camille Delouche; Sonia Dollfus; Andreas Erfurth; W Wolfgang Fleischhacker; Giulia M Giordano; Igor Gladyshev; Birte Glenthøj; Karoline Gütter; Alex Hofer; Jan Hubeňák; Stefan Kaiser; Jan Libiger; Ingrid Melle; Mette Ø Nielsen; Oleg Papsuev; Janusz K Rybakowski; Gabriele Sachs; Alp Üçok; Pawel Wojciak; Silvana Galderisi
Journal:  Eur Neuropsychopharmacol       Date:  2019-06-27       Impact factor: 4.600

8.  The Clinical Assessment Interview for Negative Symptoms (CAINS): final development and validation.

Authors:  Ann M Kring; Raquel E Gur; Jack J Blanchard; William P Horan; Steven P Reise
Journal:  Am J Psychiatry       Date:  2013-02       Impact factor: 18.112

9.  Cross Cultural Validation and Extension of the Clinical Assessment Interview for Negative Symptoms (CAINS) in the Chinese Context: Evidence from a Spectrum Perspective.

Authors:  Dong-Jie Xie; Hai-Song Shi; Simon S Y Lui; Chuan Shi; Ying Li; Karen K Y Ho; Karen S Y Hung; Wen-Xiu Li; Zheng-Hui Yi; Eric F C Cheung; Ann M Kring; Raymond C K Chan
Journal:  Schizophr Bull       Date:  2018-10-15       Impact factor: 9.306

10.  Validation of the Korean-Version of the Clinical Assessment Interview for Negative Symptoms of Schizophrenia (CAINS).

Authors:  Sung Il Jung; Jungmin Woo; Yang-Tae Kim; Sang Gyu Kwak
Journal:  J Korean Med Sci       Date:  2016-05-16       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.